Mylan Pharmaceuticals Inc., a prominent player in the global pharmaceutical industry, is headquartered in the United States. Founded in 1961, Mylan has established itself as a leader in generic and specialty medications, focusing on improving access to high-quality healthcare. With a strong operational presence across North America, Europe, and Asia, the company has made significant strides in expanding its product portfolio. Mylan is renowned for its extensive range of generic drugs, biosimilars, and over-the-counter products, which are distinguished by their affordability and accessibility. The company has achieved notable milestones, including the launch of the first generic version of the EpiPen, solidifying its market position. Mylan's commitment to innovation and quality has earned it a reputation as a trusted provider in the pharmaceutical sector, making it a key player in enhancing global health outcomes.
We don't have data for Mylan Pharmaceuticals Inc., but we can show you information about their parent organization instead.
View parent company